Anthony J. Hunt
Net Worth
Last updated:
What is Anthony J. Hunt net worth?
The estimated net worth of Mr. Anthony J. Hunt is at least $101,505,235 as of 5 Dec 2024. He owns shares worth $17,270,240 as insider, has earned $74,244,995 from insider trading and has received compensation worth at least $9,990,000 in Repligen Corporation.
What is the salary of Anthony J. Hunt?
Mr. Anthony J. Hunt salary is $1,110,000 per year as Chief Executive Officer, Pres & Director in Repligen Corporation.
How old is Anthony J. Hunt?
Mr. Anthony J. Hunt is 61 years old, born in 1964.
What stocks does Anthony J. Hunt currently own?
As insider, Mr. Anthony J. Hunt owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Repligen Corporation (RGEN) | Chief Executive Officer, Pres & Director | 139,840 | $123.5 | $17,270,240 |
What does Repligen Corporation do?
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Anthony J. Hunt insider trading
Repligen Corporation
Mr. Anthony J. Hunt has made 59 insider trades between 2016-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 50,039 units of RGEN stock on 21 May 2020. As of 5 Dec 2024 he still owns at least 139,840 units of RGEN stock.
Repligen key executives
Repligen Corporation executives and other stock owners filed with the SEC:
- Mr. Anthony J. Hunt (61) Chief Executive Officer, Pres & Director
- Mr. Jon K. Snodgres (59) Chief Financial Officer
- Mr. Ralf Kuriyel (66) Senior Vice President of R&D